Panbela Therapeutics Price on September 30, 2024

PBLADelisted Stock  USD 2.06  0.11  5.07%   
If you're considering investing in Panbela Stock, it is important to understand the factors that can impact its price. As of today, the current price of Panbela Therapeutics stands at 2.06, as last reported on the 11th of December 2024, with the highest price reaching 2.17 and the lowest price hitting 2.02 during the day. We have found twenty-three technical indicators for Panbela Therapeutics, which you can use to evaluate the volatility of the company. Please check Panbela Therapeutics' Risk Adjusted Performance of (0.13), coefficient of variation of (506.98), and Variance of 132.71 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Panbela Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PBLA
Based on monthly moving average Panbela Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Panbela Therapeutics by adding Panbela Therapeutics to a well-diversified portfolio.

Related Headline

Sonnet Biotherapeutics Headline on 30th of September 2024

CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Provides interested parties the ability to ask questions and submit topics for future videos Access the Sonnet CEO Corner here PRINCETON, NJ, Sept. 30, 2024 -- Sonnet BioTherapeutics Holdings, Inc. , a clinical-stage company developing targeted immunotherapeutic drugs, today announced the launch of its CEO Corne

Panbela Therapeutics Valuation on September 30, 2024

It is possible to determine the worth of Panbela Therapeutics on a given historical date. On September 30, 2024 Panbela was worth 2.17 at the beginning of the trading date compared to the closed value of 2.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Panbela Therapeutics stock. Still, in general, we apply an absolute valuation method to find Panbela Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Panbela Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Panbela Therapeutics' related companies.
 Open High Low Close Volume
12/11/2024
  2.17    2.17    2.02    2.06    0.00  
Backtest Panbela Therapeutics  |  Panbela Therapeutics History  |  Panbela Therapeutics Valuation 
Open Value
2.17
2.06
Closing Value
2.17
Upside

Panbela Therapeutics Trading Date Momentum on September 30, 2024

Panbela Therapeutics Fundamentals Correlations and Trends

By evaluating Panbela Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Panbela Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Panbela financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Panbela Therapeutics Stock history

Panbela Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Panbela is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Panbela Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Panbela Therapeutics stock prices may prove useful in developing a viable investing in Panbela Therapeutics
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota. Panbela Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Panbela Therapeutics Stock Technical Analysis

Panbela Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Panbela Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Panbela Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Panbela Therapeutics Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Panbela Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Panbela Therapeutics December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Panbela Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Panbela Therapeutics shares will generate the highest return on investment. By undertsting and applying Panbela Therapeutics stock market strength indicators, traders can identify Panbela Therapeutics entry and exit signals to maximize returns

Panbela Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Panbela Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Panbela Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Panbela to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Panbela Stock

If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Technical Analysis
Check basic technical indicators and analysis based on most latest market data